Marketers turn their hand to sails at Regatta
July 15, 2009Medical Communications, Sales and Marketing event, pm society, sailing
The sixth annual PM Society Sailing Regatta got off to a crashing start last month, with fine weather conditions and …
Poor antigen yields limiting H1N1 vaccine supplies, says WHO
July 15, 2009Manufacturing and Production, Research and Development h1n1, vaccines
Inadequate production capacity means that the poorest countries in the world will be denied access to vaccines for H1N1 influenza, …
BMS launches cancer website
July 15, 2009Medical Communications, Sales and Marketing BMS, Cancer, digi
Bristol-Myers Squibb has launched a new website for sufferers of chronic myeloid leukaemia (CML), a cancer of the blood. MyCMLCare.com …
Blueprint to fast track innovative drugs and devices
July 14, 2009Research and Development, Sales and Marketing ABPI, Blueprint, NHS
A new 'Blueprint' to put innovation at the heart of the NHS and help support the UK life sciences sector …
Charles River restructures as president sets retirement date
July 14, 2009Research and Development CRO, Charles River
Charles River Laboratories has unveiled a major shake-up its business and sales activities as part of a reorganisation prompted by …
Novartis extends TB donation
July 14, 2009Sales and Marketing Africa, Novartis, TB
Novartis has extended its tuberculosis (TB) drug donation programme to Tanzania. Novartis has already delivered nearly 250,000 TB treatments to …
Clinical trials market worth $50bn in 2008
July 14, 2009Research and Development CRO, strategy
The global clinical trials market topped $50 billion last year and, despite the recent downturn in the fortunes of most …
US approval boosts Plavix competitor
July 14, 2009Research and Development, Sales and Marketing Effient, FDA, US, lilly
US regulator the FDA has approved Lilly and Daiichi Sankyo's Effient, a rival treatment to the world's best-selling blood-thinning drug …
Novartis and NHS Alliance collaborate on commissioning guides
July 14, 2009Sales and Marketing NHS, Novartis, PBC
Novartis has teamed up with the NHS Alliance to launch a series of guides to help practice-based commissioning leaders tackle …
World class commissioning: 5 ways pharma can get involved
July 13, 2009Sales and Marketing NHS, commissioning, healthcare, marketing
The NHS has set its sights unambiguously on achieving World Class Commissioning. After years of being internally-focused, the health service …
Virgo launches pharma communications blog
July 13, 2009Medical Communications Virgo, digi
Specialist healthcare PR agency Virgo Health has launched a blog with the aim of stimulating debate over the future of …
Chiesi breaks ground on new R&D headquarters in Palma
July 13, 2009Research and Development Chiesi, Europe, Italy
Construction of Chiesi's new 70 million euro centre for research and development has begun in Parma, Italy. The Italian company …
Contract research sector: news in brief
July 13, 2009Research and Development Veeda
Pharmafocus presents a round-up of developments in the contract research sector, including Icon's acquisition of biomarker specialist Veeda, layoffs at …
AstraZeneca’s AZD3480 progresses in ADHD
July 11, 2009Sales and Marketing ADHD, Alzheimer's, Alzheimer's ADHD, AstraZeneca
AstraZeneca is to progress its AZD3480 (TC-1734) for attention deficit/hyperactivity disorder (ADHD) and has agreed to make a $10 million …
Adventis Health launches brand competition
July 10, 2009Medical Communications Adventis
Adventis Health has celebrated its official launch as a fully integrated healthcare communications agency. To mark this milestone, the company …
Pfizer to set up new lab in Ireland
July 10, 2009Manufacturing and Production Europe, Ireland, Pfizer
Pfizer has earmarked an 11 million euro investment for a new kilo-scale R&D facility at its manufacturing facility in Ringaskiddy, …
Biopharma company contributes to GSK’s ‘patent pool’
July 10, 2009Research and Development Orphan
Biopharma company Alnylam Pharmaceuticals is to put some of its intellectual property at the disposal of researchers into neglected tropical …
NICE to reconsider GSK’s Tyverb
July 9, 2009Research and Development, Sales and Marketing GSK, NICE, Tyverb
NICE is to reconsider Tyverb under its new lenient approach for end-of-life drugs, after GSK appealed its previous rejection of …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
